HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MSM Nutraceuticals Ends 'Drug' Production, Warned On Claims, Ingredients

Executive Summary

MSM Nutraceuticals may opt to use contract manufactures to resume marketing MSM-containing products. When it does, the firm is warned not to label and market its “MSM Pain Gel" and "MSM Nasal Spray" products as drugs.

You may also be interested in...

ED-Spiked Honey Among Latest Consumer Health Recalls

Latest updates to FDA's recalls list also includes four OTC eye drop products from MSM Nutraceuticals the agency says are not terminally sterilized and not tested per US Pharmacopeia standards, and Estee Lauder Clinique Laboratories brand Repairwear Laser Focus Line Smoothing Cream Broad Spectrum SPF 15 due to a defective container.

US DoJ Has 'Key Focus' On Supplement Industry, Adds 6 Attorneys To Sector

"It is just common sense that there's going to be fraud where you have the combination of high growth, developing science, imported products or ingredients and limited oversight," says David Morrell, deputy assistant US attorney in DoJ'd Consumer Protection Branch. CPB is adhering to executive order President Trump made earlier in 2019 instructing federal agencies to enforced based on regulations, not on guidance.

Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint

The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts